Vocal Pattern Assessment as a New Key to Identifying Rare Syndromes
NCT ID: NCT05955794
Last Updated: 2023-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
500 participants
INTERVENTIONAL
2023-09-01
2025-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary:
1. Perceptual and acoustic analysis of voice recordings
2. Development of a voice recording collection system.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retinal Thrombosis and Atherosclerosis
NCT02257333
New Biomarkers in Facioscapulohumeral Muscular Dystrophy, Multispectral Optoacoustic Tomography.
NCT05902884
Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC
NCT05969418
OCTA Insights in CNVM, Morphological Characteristics and Correlation With Structural OCT.
NCT05055973
Optical Coherence Tomography Angiography and Choroidal Osteoma
NCT05342324
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Due to the sophisticated human auditory apparatus, perceptual analysis is the basic approach for assessing voice quality. However, an objective assessment of voice quality is crucial in order to minimise errors due to perceptual and, consequently, individual analysis. Currently, the most widely used tool by researchers is Praat, although its use, being not very intuitive, can be challenging for those with little computer experience. Consequently, the use of the default settings (adult male voice) may give somewhat misleading results. To partially overcome some of the above-mentioned problems, a new user-friendly software called Biovoice has recently been developed. Recently, a number of new measurement methods have been designed to assess vocal characteristics, mainly based on the theory of non-linear dynamic systems . This theory is supported by extensive modelling studies and evidence that vocal production is a highly non-linear dynamical system, in which changes caused by alterations in the vocal organs, muscles and nerves affect the dynamics of the whole system. Consequently, these changes can be detected by means of non-linear time series analysis tools or by means of computational approaches based on artificial intelligence. This project starts from the consideration that certain genetic abnormalities that cause a specific recognisable phenotype could also result in a specific vocal phenotype, or rather a 'phonotype'. Since vocal assessment is based on non-invasive and easily administered tests, vocal characterisation could be an informative tool in the diagnostic process and help both in defining the severity of clinical pictures and in performing genotype/phenotype correlations. Furthermore, voice studies could detect and monitor the progression of symptoms in certain genetic conditions that are often characterised by a regressive trend, such as in neuromuscular or metabolic syndromes. Smartphone technology, which has already been implemented in other fields, such as in dysphonia and Parkinson's disease, can be used to collect voice recordings of syndromic patients and can be an important tool to implement computerised assessment. Unlike most smartphone-based voice analysis tools, special attention will be paid to the reliability of audio recordings, both in the laboratory and at home, which will be performed according to a strict protocol. This will allow for uniform and reliable data and results. Artificial intelligence techniques will play a key role in studying the role of voice characterisation in diagnostic work for genetic syndromes. In addition, speech analysis could support the evaluation of the effectiveness of speech therapy, drug treatment and other rehabilitation approaches.
Primary Study Objective:
The primary objective of the study is the definition of distinct vocal phenotypes and the development of an Explained Decision Support System (DSS) for the automatic detection of vocal patterns in relation to the syndrome from which the patients suffer
Secondary:
1. Perceptual and acoustic analysis of voice recordings
2. Development of a voice recording collection system.
Number of participants: 500 (400 syndromic patients plus 100 non-syndromic controls matched by gender and age).
400 patients suffering from different syndromes will be recruited, although the investigators will focus in particular on Down syndrome, Noonan, Costello, Smith-Magenis, Cri du Chat, 22q11 deletion, Williams, Crisponi, Rubinstein Taybi and CHARGE to analyse their vocal pattern characteristics. The choice of the listed conditions is guided by their prevalence in the population and previously reported peculiar vocal patterns. The patients recruited are those regularly followed by the Centre for Rare Diseases and Congenital Defects of the Agostino Gemelli IRCCS University Polyclinic Foundation, Rome. Voice recordings collected in the laboratory from syndromic patients will be analysed both perceptually and objectively and compared with a control group of non-syndromic patients, matched for age and gender.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
400 patients suffering from different syndromes will be recruited, although the investigators will focus in particular on Down syndrome, Noonan, Costello, Smith-Magenis, Cri du Chat, 22q11 deletion, Williams, Crisponi, Rubinstein Taybi and CHARGE to analyse their vocal pattern characteristics. The choice of the listed conditions is guided by their prevalence in the population and previously reported peculiar vocal patterns. The patients recruited are those regularly followed by the Centre for Rare Diseases and Congenital Defects of the Agostino Gemelli IRCCS University Polyclinic Foundation, Rome. Voice recordings collected in the laboratory from syndromic patients will be analysed both perceptually and objectively and compared with a control group of non-syndromic patients, matched for age and gender.
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patient group
500 (400 syndromic patients plus 100 non-syndromic controls matched for gender and age)
voice recordings
Experimental treatment/procedure:
The first recording will be made in the laboratory. The lab will have sound insulation (the sound-to-noise ratio of the room should be at least 30dB) to record the voice samples. Similar to the recordings made in the lab, parents/caregivers will be instructed on how to collect voice recordings at home several times during the day using a smartphone. Parents/caregivers will be asked to note down the patient's emotional state during each recording in a predefined protocol.
All patients will undergo paediatric, morphological, neurocognitive and behavioural assessment, hearing and ENT evaluation, perceptual and acoustic voice analysis.
Perceptual assessment will be done blind.The vowel recordings will be analysed by two software tools: Biovoice \[1\] and Praat \[2\].
control group
500 (400 syndromic patients plus 100 non-syndromic controls matched for gender and age)
voice recordings
Experimental treatment/procedure:
The first recording will be made in the laboratory. The lab will have sound insulation (the sound-to-noise ratio of the room should be at least 30dB) to record the voice samples. Similar to the recordings made in the lab, parents/caregivers will be instructed on how to collect voice recordings at home several times during the day using a smartphone. Parents/caregivers will be asked to note down the patient's emotional state during each recording in a predefined protocol.
All patients will undergo paediatric, morphological, neurocognitive and behavioural assessment, hearing and ENT evaluation, perceptual and acoustic voice analysis.
Perceptual assessment will be done blind.The vowel recordings will be analysed by two software tools: Biovoice \[1\] and Praat \[2\].
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
voice recordings
Experimental treatment/procedure:
The first recording will be made in the laboratory. The lab will have sound insulation (the sound-to-noise ratio of the room should be at least 30dB) to record the voice samples. Similar to the recordings made in the lab, parents/caregivers will be instructed on how to collect voice recordings at home several times during the day using a smartphone. Parents/caregivers will be asked to note down the patient's emotional state during each recording in a predefined protocol.
All patients will undergo paediatric, morphological, neurocognitive and behavioural assessment, hearing and ENT evaluation, perceptual and acoustic voice analysis.
Perceptual assessment will be done blind.The vowel recordings will be analysed by two software tools: Biovoice \[1\] and Praat \[2\].
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent from parents, legal representatives or the patients themselves, according to the instructions of the hospital's Ethics Committee.
Exclusion Criteria
* Refusal to sign the informed consent to participate in the study.
1 Year
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Florence
OTHER
Campus Bio-Medico University
OTHER
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zampino Giuseppe
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Policlinico Universitario A. Gemelli Irccs
Roma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5802
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.